Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program.
The post Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts appeared first on MedCity News.
